Back
Pacific Biosciences of California 10K Form
Sell
38
PACB
Pacific Biosciences of California
Last Price:
1.60
Seasonality Move:
21.6%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | PACB/Pacific Biosciences of California Quarterly |
| 2024-02-28 | 10K | PACB/Pacific Biosciences of California Annual |
| 2023-11-03 | 10Q | PACB/Pacific Biosciences of California Quarterly |
| 2023-08-04 | 10Q | PACB/Pacific Biosciences of California Quarterly |
| 2023-05-04 | 10Q | PACB/Pacific Biosciences of California Quarterly |
| 2023-02-28 | 10K | PACB/Pacific Biosciences of California Annual |
Receive PACB News And Ratings
See the #1 stock for the next 7 days that we like better than PACB
PACB Financial Statistics
Sales & Book Value
| Annual Sales: | $200.52M |
|---|---|
| Cash Flow: | $-44.68M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.65 |
| Price / Book: | 1.12 |
Profitability
| EPS (TTM): | -1.46000 |
|---|---|
| Net Income (TTM): | $-394.24M |
| Gross Margin: | $52.78M |
| Return on Equity: | -64.42% |
| Return on Assets: | -23.83% |
Pacific Biosciences of California Earnings Forecast
Key Pacific Biosciences of California Financial Ratios
- The Gross Profit Margin over the past 17 years for PACB is 26.32%.
- The Selling, General & Administrative Expenses for PACB have been equal to 84.69% of Gross Profit Margin.
- The Research & Development expenses have been 93.34% of Revenue.
- The Interest Expense is -4.68% of Operating Income.
- The Net Earning history of PACB is -152.97% of Total Revenues.
- Per Share Earnings over the last 17 years have been positive in 10 years.
Pacific Biosciences of California Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | PACB |
| CUSIP: | 69404D |
| Website: | pacb.com |
Debt
| Debt-to-Equity Ratio: | 1.97 |
|---|---|
| Current Ratio: | 9.74 |
| Quick Ratio: | 8.34 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PACB Technical Analysis vs Fundamental Analysis
Sell
38
Pacific Biosciences of California (PACB)
is a Sell
Is Pacific Biosciences of California a Buy or a Sell?
-
Pacific Biosciences of California stock is rated a Sell
The current Pacific Biosciences of California [PACB] share price is $1.60. The Score for PACB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.